Skip to main content

Find Clinical Trials

Home
Conditions
Dementia

Clinical trial condition

Dementia

Explore clinical trials studying Dementia. Study availability and eligibility vary by location and protocol.

2,729 public trials 505 recruiting studies

Refine in advanced search Browse all conditions

Dementia trial results

Completed

Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

NCT00471211

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Sydney, New South Wales, Australia

Sydney, New South Wales, Australia

Adelaide, South Australia, Australia

Melbourne, Victoria, Australia

View all 15 locations

View Trial Details

Completed

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

NCT00334906

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Forest Laboratories Jersey City, New Jersey, United States

View Trial Details

Completed

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

NCT00387270

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Huntington Study Group Rochester, New York, United States

View Trial Details

Completed

The Impact of Lorazepam on Cognition in APOE e4 Carriers

NCT00586430

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

View Trial Details

Completed

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

NCT00499642

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Rennes, France

Rueil-Malmaison, France

View Trial Details

Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

NCT00146211

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

University of California San Diego La Jolla, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 41 locations

View Trial Details

Completed

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

NCT00480818

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Rennes, France

View Trial Details

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects

NCT00479700

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Single Ascending Dose Study of SRA-444 in Healthy Subjects

NCT00452504

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Zuidlaren, Netherlands

View Trial Details

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males

NCT00480467

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Ibaraki Pref, Japan

View Trial Details